ESMO 2017 | Pharmacovigilance and the purpose of clinical trials

Diana Lüftner, from the Humboldt University, Berlin, Germany speaks to us from the 2017 European Society for Medical Oncology (ESMO) conference held in Madrid, Spain, discussing clinical trials from a clinician’s point of view. Prof. Lüftner explains their purpose and what clinicians look for in a trial, and tells us the importance of reducing drug interchangeability during a patient’s course of treatment.